Publications by authors named "Bo Lindmark"

Claim this Profile
M
Meeting report: DMDG peptide and oligonucleotide ADME workshop 2024.
Inga Bjørnsdottir, Ralf Lotz, Bo Lindmark, Steve Hood, Jesper Kammersgaard Christensen

Xenobiotica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participants.
Xue-Qing Li, Bo Lindmark, Carl Amilon, Kristin Samuelsson, Lars Weidolf

Pharmacol Res Perspect· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects.
Bo Lindmark, Xue-Qing Li, Chandrali Bhattacharya, Greggory Housler, Maria Heijer

Drug Metab Dispos· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated drug discovery by rapid candidate drug identification.
Fredrik Bergström, Bo Lindmark

Drug Discov Today· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection.
Kenneth L Granberg, Zhong-Qing Yuan, Bo Lindmark, Karl Edman, Johan Kajanus

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human hepatocytes and cytochrome P450-selective inhibitors predict variability in human drug exposure more accurately than human recombinant P450s.
Bo Lindmark, Anna Lundahl, Kajsa P Kanebratt, Tommy B Andersson, Emre M Isin

Br J Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity.
Anneli Nordqvist, Gavin O'Mahony, Maria Fridén-Saxin, Marlene Fredenwall, Anders Hogner, Bo Lindmark

ChemMedChem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time dependent analysis of assay comparability: a novel approach to understand intra- and inter-site variability over time.
Susanne Winiwarter, Brian Middleton, Barry Jones, Paul Courtney, Bo Lindmark

J Comput Aided Mol Des· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes.
Therese Admyre, Lena Amrot-Fors, Maria Andersson, Martin Bauer, Mikael Bjursell, Bo Lindmark

Chem Biol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).
Jonas G Barlind, Udo A Bauer, Alan M Birch, Susan Birtles, Linda K Buckett, Bo T Lindmark

J Med Chem· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective determination of felodipine in human plasma by chiral normal-phase liquid chromatography and electrospray ionisation mass spectrometry.
Bo Lindmark, Martin Ahnoff, Bengt-Arne Persson

J Pharm Biomed Anal· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometry.
Marita Larsson, Ulrika Logren, Martin Ahnoff, Bo Lindmark, Peter Abrahamsson

J Chromatogr B Analyt Technol Biomed Life Sci· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients.
H Ericsson, J Schwieler, B O Lindmark, P Löfdahl, T Thulin

Chirality· April 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis